These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22579742)

  • 1. Carbon nanotube exploration in cancer cell lines.
    Kesharwani P; Ghanghoria R; Jain NK
    Drug Discov Today; 2012 Sep; 17(17-18):1023-30. PubMed ID: 22579742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating the anticancer potential of carbon nanotube-based therapeutics through cell line testing.
    Kesharwani P; Mishra V; Jain NK
    Drug Discov Today; 2015 Sep; 20(9):1049-60. PubMed ID: 25997997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotubes in biological applications.
    Mundra RV; Wu X; Sauer J; Dordick JS; Kane RS
    Curr Opin Biotechnol; 2014 Aug; 28():25-32. PubMed ID: 24832071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth.
    Hampel S; Kunze D; Haase D; Krämer K; Rauschenbach M; Ritschel M; Leonhardt A; Thomas J; Oswald S; Hoffmann V; Büchner B
    Nanomedicine (Lond); 2008 Apr; 3(2):175-82. PubMed ID: 18373424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy.
    Prakash S; Malhotra M; Shao W; Tomaro-Duchesneau C; Abbasi S
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1340-51. PubMed ID: 21756952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon nanotubes in cancer therapy: a more precise look at the role of carbon nanotube-polymer interactions.
    Adeli M; Soleyman R; Beiranvand Z; Madani F
    Chem Soc Rev; 2013 Jun; 42(12):5231-56. PubMed ID: 23443245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors.
    Singh R; Pantarotto D; McCarthy D; Chaloin O; Hoebeke J; Partidos CD; Briand JP; Prato M; Bianco A; Kostarelos K
    J Am Chem Soc; 2005 Mar; 127(12):4388-96. PubMed ID: 15783221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug.
    Mahmood M; Karmakar A; Fejleh A; Mocan T; Iancu C; Mocan L; Iancu DT; Xu Y; Dervishi E; Li Z; Biris AR; Agarwal R; Ali N; Galanzha EI; Biris AS; Zharov VP
    Nanomedicine (Lond); 2009 Dec; 4(8):883-93. PubMed ID: 19958225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma.
    Chaudhuri P; Soni S; Sengupta S
    Nanotechnology; 2010 Jan; 21(2):025102. PubMed ID: 19955607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon-based drug delivery carriers for cancer therapy.
    Lim DJ; Sim M; Oh L; Lim K; Park H
    Arch Pharm Res; 2014 Jan; 37(1):43-52. PubMed ID: 24234911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting carbon nanotubes against cancer.
    Fabbro C; Ali-Boucetta H; Da Ros T; Kostarelos K; Bianco A; Prato M
    Chem Commun (Camb); 2012 Apr; 48(33):3911-26. PubMed ID: 22428156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the research of carbon nanotubes as drug carriers].
    Yu JG; Huang KL; Yang QQ; Liu SQ; Tang JC
    Yao Xue Xue Bao; 2008 Oct; 43(10):985-91. PubMed ID: 19127860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SiRNA delivery with functionalized carbon nanotubes.
    Varkouhi AK; Foillard S; Lammers T; Schiffelers RM; Doris E; Hennink WE; Storm G
    Int J Pharm; 2011 Sep; 416(2):419-25. PubMed ID: 21320582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of cytotoxicity of engineered carbon nanotubes in selected human cell lines.
    Hu X; Cook S; Wang P; Hwang HM; Liu X; Williams QL
    Sci Total Environ; 2010 Mar; 408(8):1812-7. PubMed ID: 20167353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of Carbon Nanotubes as Anti-Tumor Drug Carriers.
    Yan H; Xue Z; Xie J; Dong Y; Ma Z; Sun X; Kebebe Borga D; Liu Z; Li J
    Int J Nanomedicine; 2019; 14():10179-10194. PubMed ID: 32021160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon nanotube uptake and toxicity in the brain.
    Zhang L; Alizadeh D; Badie B
    Methods Mol Biol; 2010; 625():55-65. PubMed ID: 20422381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interfacing carbon nanotubes with living mammalian cells and cytotoxicity issues.
    Cui HF; Vashist SK; Al-Rubeaan K; Luong JH; Sheu FS
    Chem Res Toxicol; 2010 Jul; 23(7):1131-47. PubMed ID: 20402485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy.
    Meng J; Meng J; Duan J; Kong H; Li L; Wang C; Xie S; Chen S; Gu N; Xu H; Yang XD
    Small; 2008 Sep; 4(9):1364-70. PubMed ID: 18720440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focused actions to protect carbon nanotube workers.
    Schulte PA; Kuempel ED; Zumwalde RD; Geraci CL; Schubauer-Berigan MK; Castranova V; Hodson L; Murashov V; Dahm MM; Ellenbecker M
    Am J Ind Med; 2012 May; 55(5):395-411. PubMed ID: 22392774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-walled carbon nanotubes dispersed in aqueous media via non-covalent functionalization: effect of dispersant on the stability, cytotoxicity, and epigenetic toxicity of nanotube suspensions.
    Alpatova AL; Shan W; Babica P; Upham BL; Rogensues AR; Masten SJ; Drown E; Mohanty AK; Alocilja EC; Tarabara VV
    Water Res; 2010 Jan; 44(2):505-20. PubMed ID: 19945136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.